BackImugene Limited Overview

Imugene Limited Receivables

Imugene Limited's receivables is $2.4M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$2.37M
↓ 76.32% YoYΔ $-7.65M vs prior year quarter

Peer trimmed avg / median

Loading

Imugene Limited Receivables History

Loading

Imugene Limited vs. peers: Receivables Comparison

Loading

Imugene Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Imugene Limited (IUGNF) FAQ

As of the most recent data (June 2026), IUGNF shows a receivables of $2.4M. That compares with $10M in the prior-year period — down 76.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IUGNF's receivables is now $2.4M (was $10M) — a 76.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Imugene Limited is outperforming or lagging.

Tracking IUGNF's receivables over time shows whether Imugene Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $2.4M That compares with $10M in the prior-year period — down 76.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Imugene Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $2.4M) with ownership activity and broader fundamentals.

Imugene Limited's receivables is $2.4M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.

Questions & Answers